Fig. 3
From: SCUBE3 serves as an independent poor prognostic factor in breast cancer
UALCAN analysis for the correlation between SCUBE3 mRNA expression level and clinicopathological parameters of breast cancer. (a) patient’s age (21–40, 41–60, 61–80, and 81–100), (b) node metastasis status (N0, N1, N2, and N3), (c) individual cancer stage (stage 1, stage 2, stage 3, and stage 4), (d) subclasses (luminal, HER2 + , and triple-negative)